Genzyme Transgenics deal

GZTC (Framingham, Mass.) will purchase Biodevelopment Laboratories for $6 million. GZTC will issue common shares with a value of $2.6 million and will assume Biodevelopment's $2.7 million of outstanding debt, in addition to other considerations. ...